<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>{{ _('References') }} - {{ _('Minimum Retesting Intervals') }}</title>
    <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.0/dist/css/bootstrap.min.css" rel="stylesheet">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap-icons@1.10.0/font/bootstrap-icons.css">
</head>
<body>
<div class="container py-4">
    <!-- Navigation Bar -->
    <div class="row mb-3">
        <div class="col-12">
            <nav class="navbar navbar-expand-lg navbar-light bg-light rounded">
                <div class="container-fluid">
                    <div class="navbar-nav me-auto">
                        <a class="nav-link" href="{{ url_for('index') }}">
                            <i class="bi bi-house"></i> {{ _('Search') }}
                        </a>
                        <a class="nav-link active" href="{{ url_for('references') }}">
                            <i class="bi bi-book"></i> {{ _('References') }}
                        </a>
                        <a class="nav-link" href="{{ url_for('evidence_levels') }}">
                            <i class="bi bi-clipboard-check"></i> {{ _('Evidence Levels') }}
                        </a>
                        <a class="nav-link" href="{{ url_for('abbreviations') }}">
                            <i class="bi bi-list-ul"></i> {{ _('Abbreviations') }}
                        </a>
                        <a class="nav-link" href="https://www.rcpath.org/static/253e8950-3721-4aa2-8ddd4bd94f73040e/g147_national-minimum_retesting_intervals_in_pathology.pdf" target="_blank">
                            <i class="bi bi-file-pdf"></i> {{ _('Original PDF') }}
                        </a>
                    </div>
                    <div class="dropdown">
                        <button class="btn btn-secondary dropdown-toggle" type="button" id="languageMenuButton" data-bs-toggle="dropdown" aria-expanded="false">
                            {{ _('Language') }}
                        </button>
                        <ul class="dropdown-menu" aria-labelledby="languageMenuButton">
                            <li><a class="dropdown-item" href="{{ url_for('set_language', language='en') }}">English</a></li>
                            <li><a class="dropdown-item" href="{{ url_for('set_language', language='de') }}">Deutsch</a></li>
                        </ul>
                    </div>
                </div>
            </nav>
        </div>
    </div>
    
    <div class="d-flex justify-content-between align-items-center mb-4">
        <h1>{{ _('References') }}</h1>
    </div>
    
    <nav aria-label="breadcrumb" class="mb-4">
        <ol class="breadcrumb">
            <li class="breadcrumb-item"><a href="{{ url_for('index') }}">{{ _('Home') }}</a></li>
            <li class="breadcrumb-item active" aria-current="page">{{ _('References') }}</li>
        </ol>
    </nav>
    
    <div class="row">
        <div class="col-12">
            <div class="card">
                <div class="card-header">
                    <h5 class="mb-0">{{ _('References from National Minimum Retesting Intervals in Pathology') }}</h5>
                </div>
                <div class="card-body">
                    <div class="alert alert-info">
                        <strong>{{ _('Source:') }}</strong> 
                        <a href="https://www.rcpath.org/static/253e8950-3721-4aa2-8ddd4bd94f73040e/g147_national-minimum_retesting_intervals_in_pathology.pdf" 
                           target="_blank" class="alert-link">
                            {{ _('National minimum retesting intervals in pathology (PDF)') }}
                        </a>
                        <br>
                        <small class="text-muted">{{ _('Pages 72-78') }}</small>
                    </div>
                    
                    <div class="table-responsive">
                        <table class="table table-striped table-sm">
                            <thead class="table-dark">
                                <tr>
                                    <th style="width: 60px;">{{ _('No.') }}</th>
                                    <th>{{ _('Reference') }}</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr><td><strong>1</strong></td><td>Berg J, Lane V. Pathology Harmony; a pragmatic and scientific approach to unfounded variation in the clinical laboratory. Ann Clin Biochem 2011;48:195–197.</td></tr>
                                <tr><td><strong>2</strong></td><td>Smellie WS, Association for Clinical Biochemistry's Clinical Practice Section. Time to harmonise common laboratory test profiles. BMJ 2012;344:e11693.</td></tr>
                                <tr><td><strong>3</strong></td><td>Lang T. National Minimum Re-testing Interval Project: A final report detailing consensus recommendations for minimum retesting intervals for use in Clinical Biochemistry. London, UK: Association of Clinical Biochemistry and Laboratory Medicine, 2013.</td></tr>
                                <tr><td><strong>4</strong></td><td>Smellie WS, Finnigan DI, Wilson D, Freedman D, McNulty CA, Clark GJ. Methodology for constructing guidance. J Clin Pathol 2005;58:249–253.</td></tr>
                                <tr><td><strong>5</strong></td><td>Glaser EM. Using behavioral science strategies for defining the state-of-the-art. J App Behavioral Sci 1980;16:79–92.</td></tr>
                                <tr><td><strong>6</strong></td><td>Guidelines and Audit Implementation Network (GAIN). Hyponatraemia in Adults (On or After 16th Birthday). Belfast, UK: GAIN, 2010.</td></tr>
                                <tr><td><strong>7</strong></td><td>The Renal Association. Clinical Practice Guidelines. Acute Kidney Injury (5th edition). Hampshire, UK: The Renal Association, 2011.</td></tr>
                                <tr><td><strong>8</strong></td><td>NICE Clinical Knowledge Summary. Hypertension – Not Diabetic. Accessed July 2019. Available at: https://cks.nice.org.uk/hypertension-not-diabetic</td></tr>
                                <tr><td><strong>9</strong></td><td>GAIN and the Northern Ireland Nephrology Forum. Northern Ireland Guidelines for the Management of Chronic Kidney Disease (CKD) Practical Points for Use of Estimated GFR and Albuminuria (ACR) in Assessing CKD. Belfast, UK: GAIN, 2015.</td></tr>
                                <tr><td><strong>10</strong></td><td>NICE Clinical Knowledge Summary. Atrial Fibrillation. Accessed July 2019. Available at: http://cks.nice.org.uk/atrial-fibrillation</td></tr>
                                <tr><td><strong>11</strong></td><td>NICE Clinical Knowledge Summary. Heart Failure – Chronic. Accessed July 2019. Available at: http://cks.nice.org.uk/heart-failure-chronic</td></tr>
                                <tr><td><strong>12</strong></td><td>National Public Health Service for Wales. Drug Monitoring: A Risk Management System (1st revision). NPHS: Wales, 2008.</td></tr>
                                <tr><td><strong>13</strong></td><td>NICE Clinical Knowledge Summary. Crohn's Disease. Accessed July 2019. Available at: http://cks.nice.org.uk/crohns-disease#!prescribinginfo</td></tr>
                                <tr><td><strong>14</strong></td><td>Clinical Knowledge Summary. Bipolar Disease. Accessed July 2019. Available at: http://cks.nice.org.uk/bipolar-disorder#!prescribinginfosub:1</td></tr>
                                <tr><td><strong>15</strong></td><td>NICE. Chronic Kidney Disease in Adults: Assessment and Management. London, UK: NICE, 2014. Available at: www.nice.org.uk/guidance/cg182</td></tr>
                                <tr><td><strong>16</strong></td><td>The Royal College of Radiologists. Standards for Intravascular Contrast Agent Administration to Adult Patients (3rd edition). London, UK: Royal College of Radiologists, 2015.</td></tr>
                                <tr><td><strong>17</strong></td><td>Krutzén E, Bäck SE, Nilsson-Ehle I, Nilsson-Ehle P. Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate. J Lab Clin Med 1984;104:955–961.</td></tr>
                                <tr><td><strong>18</strong></td><td>Sattar N, Welsh P, Panarelli M, Forouhi NG.Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet 2012;379:95–96.</td></tr>
                                <tr><td><strong>19</strong></td><td>Sattar N, Welsh P, Panarelli M, Forouhi NG. Vitamin D testing — Authors' reply. Lancet 2012;379:1700–1701.</td></tr>
                                <tr><td><strong>20</strong></td><td>The Renal Association. CKD-Mineral and Bone Disorders (CKD-MBD). Bristol, UK: The Renal Association, 2015.</td></tr>
                                <tr><td><strong>21</strong></td><td>Smellie S, Galloway M, McNulty S. Primary Care and Laboratory Medicine, Frequently Asked Questions. London, UK: ACB Venture Publications, 2011.</td></tr>
                                <tr><td><strong>22</strong></td><td>NICE Clinical Knowledge Summaries. Lipid Therapy − Primary Prevention of CVD. Accessed July 2019. Available at: https://cks.nice.org.uk/lipid-modification-cvd-prevention#!scenario</td></tr>
                                <tr><td><strong>23</strong></td><td>Smellie WSA, Wilson D, McNulty CAM, Galloway MJ, Spickett GA, Finnigan DI et al. Best practice in primary care pathology: review 1. J Clin Pathol 2005;58:1016–1024.</td></tr>
                                <tr><td><strong>24</strong></td><td>Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011;21:593–646.</td></tr>
                                <tr><td><strong>25</strong></td><td>Association for Clinical Biochemistry, British Thyroid Association and British Thyroid Foundation. UK Guidelines for the Use of Thyroid Function Tests. London, UK: Association for Clinical Biochemistry, British Thyroid Association, 2006.</td></tr>
                                <tr><td><strong>26</strong></td><td>British Thyroid Association, Royal College of Physicians. Guidelines for the Management of Thyroid Cancer (3rd edition). London: Royal College of Physicians, 2014.</td></tr>
                                <tr><td><strong>27</strong></td><td>Laure Giraudet A, Al Ghulzan A, Aupérin A, Leboulleux S, Chehboun A, Troalen F et al. Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times. Eur J Endocrinol 2008;158: 239–246.</td></tr>
                                <tr><td><strong>28</strong></td><td>NICE. Fertility Problems: Assessment and Treatment. London, UK: NICE, 2013. www.nice.org.uk/guidance/cg156</td></tr>
                                <tr><td><strong>29</strong></td><td>NICE. Guideline NG23 Menopause: Diagnosis and Management. Available at: www.nice.org.uk/guidance/ng23</td></tr>
                                <tr><td><strong>30</strong></td><td>Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 2006;65:265–273.</td></tr>
                                <tr><td><strong>31</strong></td><td>Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:273–288.</td></tr>
                                <tr><td><strong>32</strong></td><td>American Diabetes Association. Clinical practice recommendations. Diabetes Care 2012;35 (Supplement 1):S11–S63.</td></tr>
                                <tr><td><strong>33</strong></td><td>World Health Organisation. Use of Glycated Haemoglobin (HbA1C) in the Diagnosis of Diabetes Mellitus. Geneva, Switzerland: WHO, 2011.</td></tr>
                                <tr><td><strong>34</strong></td><td>NICE. Type 2 Diabetes. London: NICE, 2015. Available at: www.nice.org.uk/guidance/ng28</td></tr>
                                <tr><td><strong>35</strong></td><td>Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS et al. Testosterone therapy in adult men with androgen deficiency syndromes Endocrine Society CG. J Clin Endocrinol Metab 2010;95:2536–2559.</td></tr>
                                <tr><td><strong>36</strong></td><td>Petak SM, Nankin HR, Spark RF, Swerdloff RS, Rodriguez-Rigau LJ. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients—2002 update. Endocr Pract 2002;8:440–456.</td></tr>
                                <tr><td><strong>37</strong></td><td>Martin KA, Chang RJ, Ehrmann DA, Ibanez L, Lobo RA, Rosenfield RL et al. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008;93:1105–1120.</td></tr>
                                <tr><td><strong>38</strong></td><td>Ho KK, GH Deficiency Consensus Workshop Participants. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society and Endocrine Society of Australia. Europ J Endocrinol 2007;157:695–700.</td></tr>
                                <tr><td><strong>39</strong></td><td>Growth Hormone Research Society, Pituitary Society. Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of Growth Hormone Research Society and Pituitary Society. J Clin Endocrinol Metab 2004;89:3099–3102.</td></tr>
                                <tr><td><strong>40</strong></td><td>Wu AHB, Christenson RH, Greene DN, Jaffe AS, Kavsak PA, Ordonez-Llanos J et al. Clinical laboratory practice recommendations for the use of cardiac troponin in acute coronary syndrome: expert opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem 2018;64:645–655.</td></tr>
                                <tr><td><strong>41</strong></td><td>Boeddinghaus J, Twerenbold R, Nestelberger T, Badertscher P, Wildi K, Puelacher C et al. Clinical validation of a novel high-sensitivity cardiac troponin I assay for early diagnosis of acute myocardial infarction. Clin Chem 2018;64:1347–1360.</td></tr>
                                <tr><td><strong>42</strong></td><td>Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011;32:2999–3054.</td></tr>
                                <tr><td><strong>43</strong></td><td>Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010;31:2197–2204.</td></tr>
                                <tr><td><strong>44</strong></td><td>Croal BL, Hillis GS, Gibson PH, Fazal MT, El-Shafei H, Gibson G et al. The relationship between post-operative cardiac troponin I levels and outcome from cardiac surgery. Circulation 2006;114:1468–1475.</td></tr>
                                <tr><td><strong>45</strong></td><td>Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005;112:3088–3096.</td></tr>
                                <tr><td><strong>46</strong></td><td>NICE. Chronic Heart Failure: Management. London, UK: NICE, 2010. Available at: www.nice.org.uk/guidance/CG108</td></tr>
                                <tr><td><strong>47</strong></td><td>NICE. Acute Heart Failure: Management. London, UK: NICE 2014. Available at: www.nice.org.uk/guidance/CG187</td></tr>
                                <tr><td><strong>48</strong></td><td>NICE. Chronic Heart Failure in Adults: Diagnosis and Management. London, UK: NICE, 2018. Available at: www.nice.org.uk/guidance/ng106</td></tr>
                                <tr><td><strong>49</strong></td><td>Wolters Kluwer. UpToDate. Accessed July 2019. Available at: www.uptodate.com</td></tr>
                                <tr><td><strong>50</strong></td><td>Molinari I, Souare K, Lamireau T, Fayon M, Lemieux C, Cassaigne A et al. Fecal chymotrypsin and elastase-1 determination on one single stool collected at random: diagnostic value for exocrine pancreatic status. Clin Biochem 2004;37:758–763.</td></tr>
                                <tr><td><strong>51</strong></td><td>van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010;341:c3369.</td></tr>
                                <tr><td><strong>52</strong></td><td>Turvill J, Turnock D, Holmes H, Jones A, Mclaughlan E, Hilton V et al. Evaluation of the clinical and cost-effectiveness of the York Faecal Calprotectin Care Pathway. Frontline Gastroenterol 2018;9:285–294.</td></tr>
                                <tr><td><strong>53</strong></td><td>NICE. Nutrition Support in Adults: Oral Nutrition Support, Enteral Tube Feeding and Parenteral Nutrition. London, UK: NICE, 2006. Available at: www.nice.org.uk/guidance/CG32</td></tr>
                                <tr><td><strong>54</strong></td><td>European Association for the Study of the Liver. EASL clinical practice guidelines for HFE hemochromatosis. J Hepatol 2010;53:3–22.</td></tr>
                                <tr><td><strong>55</strong></td><td>British Society for Haematology. Diagnosis and Therapy of Genetic Haemochromatosis (Review and 2017 Update). London, UK: British Society for Haematology, 2018</td></tr>
                                <tr><td><strong>56</strong></td><td>Goddard AF, James MW, McIntyre AS, Scott BB, British Society of Gastroenterology. Guidelines for the management of iron deficiency anaemia. Gut 2011;60:1309–1316.</td></tr>
                                <tr><td><strong>57</strong></td><td>GAIN. Investigation and Management of the Adult Patient with Anaemia Microcytic Anaemia. Available at: www.rqia.org.uk/RQIA/files/1e/1e2a9adc-7517-4a47-858a-5192b0746456.pdf</td></tr>
                                <tr><td><strong>58</strong></td><td>NICE guideline. Chronic Kidney Disease: Managing Anaemia. London, UK: NICE, 2015. Available at: www.nice.org.uk/guidance/ng8</td></tr>
                                <tr><td><strong>59</strong></td><td>Smellie WS, Forth J, Bareford D, Twomey P, Galloway MJ, Logan EC et al. Best practice in primary care pathology: review 3. J Clin Pathol 2006;59:781–789.</td></tr>
                                <tr><td><strong>60</strong></td><td>Clinical Knowledge Summary. Anaemia – B12 and Folate Deficiency. Accessed July 2019. Available at: http://cks.nice.org.uk/anaemia-b12-and-folate-deficiency</td></tr>
                                <tr><td><strong>61</strong></td><td>Bird J, Behrens J, Westin J, Turesson I, Drayson M, Beetham R et al. UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS). Brit J Haemat 2009:147;22–42.</td></tr>
                                <tr><td><strong>62</strong></td><td>UK Primary Immunodeficiency Network. Standards of Care: CVID Diagnosis and Management (Version 2). Newcastle, UK: UK Primary Immunodeficiency Network, 2011.</td></tr>
                                <tr><td><strong>63</strong></td><td>Hutton HD, Drummond HS, Fryer AA. The rise and fall of C-reactive protein: managing demand within clinical biochemistry. Ann Clin Biochem 2009;46:155–158.</td></tr>
                                <tr><td><strong>64</strong></td><td>Hochreiter M, Köhler T, Schweiger AM, Keck FS, Bein B, von Spiegel T et al. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care 2009;13:R83.</td></tr>
                                <tr><td><strong>65</strong></td><td>Seguela PE, Joram N, Romefort B, Manteau C, Orsonneau JL, Branger B et al. Procalcitonin as a marker of bacterial infection in children undergoing cardiac surgery with cardiopulmonary bypass. Cardiol Young 2011;21:392–399.</td></tr>
                                <tr><td><strong>66</strong></td><td>Sturgeon CM, Duffy MJ, Hofmann BR, Lamerz R, Fritsche HA, Gaarenstroom K et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem 2010:56;e1–48.</td></tr>
                                <tr><td><strong>67</strong></td><td>NICE. Ovarian Cancer: The Recognition and Initial Management. London, UK: NICE, 2011. Available at: www.nice.org.uk/guidance/CG122</td></tr>
                                <tr><td><strong>68</strong></td><td>Public Health England. Prostate Cancer Risk Management Programme: Overview. Accessed July 2019. Available at: www.cancerscreening.nhs.uk/prostate/index.html</td></tr>
                                <tr><td><strong>69</strong></td><td>Smellie WS, Forth J, Sundar S, Kalu E, McNulty CA, Sherriff E et al. Best practice in primary care pathology: review 4. J Clin Pathol 2006;59:1116.</td></tr>
                                <tr><td><strong>70</strong></td><td>Molina R, Barak V, van Dalen A, Duffy MJ, Einarsson R, Gion M et al. Tumor markers in breast cancer – European Group on Tumor Markers recommendations. Tumour Biol 2005;26:281–293.</td></tr>
                                <tr><td><strong>71</strong></td><td>Bidart JM, Thuillier F, Augereau C, Chalas J, Daver A, Jacob N et al. Kinetics of serum tumour marker concentrations and usefulness in clinical monitoring. Clin Chem 1999;45:1695–1707.</td></tr>
                                <tr><td><strong>72</strong></td><td>Sturgeon CM, Hoffman BR, Chan DW, Ch'ng SL, Hammond E, Hayes DF et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines use of tumour markers in clinical practice: quality requirements. Clin Chem 2008;54:1935–1939.</td></tr>
                                <tr><td><strong>73</strong></td><td>Brunton LL, Chabner BA, Knollman BC (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics (12th edition). New York, USA: McGraw-Hill, 2011.</td></tr>
                                <tr><td><strong>74</strong></td><td>Baker R, Jardine A, Andrews P. Post-operative Care of the Kidney Transplant Recipient. Hampshire, UK: The Renal Association, 2011.</td></tr>
                                <tr><td><strong>75</strong></td><td>Piard C, Bressolle F, Fakhoury M, Zhang D, Yacouben K, Rieutord A et al. A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol 2007;60:609–620.</td></tr>
                                <tr><td><strong>76</strong></td><td>Joint Formulary Committee. British National Formulary (77th edition). London, UK: BMJ Group and Pharmaceutical Press, 2019.</td></tr>
                                <tr><td><strong>77</strong></td><td>Health and Safety Executive. Control of Lead at Work (3rd edition). Surrey, UK: HSE Books, 2002.</td></tr>
                                <tr><td><strong>78</strong></td><td>TOXBASE. TOXBASE. Accessed July 2019. Available at: www.toxbase.org</td></tr>
                                <tr><td><strong>79</strong></td><td>NICE. Ectopic Pregnancy and Miscarriage: Diagnosis and Initial Management. London, UK: NICE, 2019. Available at: www.nice.org.uk/guidance/ng126</td></tr>
                                <tr><td><strong>80</strong></td><td>Royal College of Obstetricians and Gynaecologists. Obstetric Cholestasis: Green-top Guideline No 43. London, UK: Royal College of Obstetricians and Gynaecologists, 2011.</td></tr>
                                <tr><td><strong>81</strong></td><td>NICE. Antenatal Care for Uncomplicated Pregnancies. London, UK: NICE, 2008. Available at: www.nice.org.uk/guidance/cg62</td></tr>
                                <tr><td><strong>82</strong></td><td>NICE. Hypertension in Pregnancy: Diagnosis and Management. London, UK: NICE, 2019. Available at: www.nice.org.uk/guidance/ng133</td></tr>
                                <tr><td><strong>83</strong></td><td>Royal College of Obstetricians and Gynaecologists. Severe Pre-eclampsia/Eclampsia, Management: Green-top Guideline No 10A. London, UK: Royal College of Obstetricians and Gynaecologists, 2006.</td></tr>
                                <tr><td><strong>84</strong></td><td>Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011;21:1081–1125.</td></tr>
                                <tr><td><strong>85</strong></td><td>NICE. Diabetes in Pregnancy: Management from Preconception to the Postnatal Period. London, UK: NICE: 2015. Available at: https://www.nice.org.uk/guidance/ng3</td></tr>
                                <tr><td><strong>86</strong></td><td>GAIN. Management of Hyponatraemia in Labour and the Immediate Postpartum Period. Belfast, UK: GAIN, 2017.</td></tr>
                                <tr><td><strong>87</strong></td><td>NICE. Type 1 Diabetes: Diagnosis and Management of Type 1 Diabetes in Children and Young People. London, UK: NICE, 2004.</td></tr>
                                <tr><td><strong>88</strong></td><td>Murch S, Jenkins H, Auth M, Bremner R, Butt A, France S et al. Joint BSPGHAN and Coeliac UK guidelines for the diagnosis and management of coeliac disease in children. Arch Dis Child 2013;98:806–811.</td></tr>
                                <tr><td><strong>89</strong></td><td>Thomas D, Wee M, Clyburn P, Walker I, Brohi K, Collins P et al. Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia 2010;65:1153–1161.</td></tr>
                                <tr><td><strong>90</strong></td><td>British Committee for Standards in Haematology. UK Guidelines on the Management of Iron Deficiency in Pregnancy. London, UK: BCSH, 2011.</td></tr>
                                <tr><td><strong>91</strong></td><td>Dasgupta B, Borg FA, Hassan N, Barraclough K, Bourke B, Fulcher J et al. BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology 2010;49:186–190.</td></tr>
                                <tr><td><strong>92</strong></td><td>NICE. Rheumatoid Arthritis: The Management of Rheumatoid Arthritis in Adults. London, UK: NICE, 2009. Available at: www.nice.org.uk/guidance/CG79</td></tr>
                                <tr><td><strong>93</strong></td><td>Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial. Ann Intern Med 1993;119:874–881.</td></tr>
                                <tr><td><strong>94</strong></td><td>Keeling D, Mackie I, Moore GW, Greer IA, Greaves M, British Committee for Standards in Haematology. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol 2012;157:47–58.</td></tr>
                                <tr><td><strong>95</strong></td><td>Collins PW, Chalmers E, Hart DP, Liesner R, Rangarajan S, Talks K et al. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization. Br J Haematol 2013;160:153–170.</td></tr>
                                <tr><td><strong>96</strong></td><td>Collins PW, Chalmers E, Hart D, Jennings I, Liesner R, Rangarajan S et al. Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO. Br J Haematol 2013;162:758–773.</td></tr>
                                <tr><td><strong>97</strong></td><td>Milkins C, Berryman J, Cantwell C, Elliott C, Haggas R et al. British Committee for Standards in Haematology, Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology. Transfus Med 2013;23:3–35.</td></tr>
                                <tr><td><strong>98</strong></td><td>White J, Qureshi H, Massey E, Needs M, Byrne G, Daniels G et al. Guideline for blood grouping and red cell antibody testing in pregnancy British Committee for Standards in Haematology. Transfus Med 2016;26:246–263.</td></tr>
                                <tr><td><strong>99</strong></td><td>Qureshi H, Massey E, Kirwan D, Davies T, Robson S, White J et al. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med 2014;24:8–20.</td></tr>
                                <tr><td><strong>100</strong></td><td>NICE. Rheumatoid arthritis in adults: management. London, UK: NICE, 2018. Available at: www.nice.org.uk/guidance/ng100</td></tr>
                                <tr><td><strong>101</strong></td><td>Tarzi MD, Hickey A, Förster T, Mohammadi M, Longhurst HJ. An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angioedema. Clin Exp Immunol 2007;149:513–516.</td></tr>
                                <tr><td><strong>102</strong></td><td>Abraham M, Khosroshahi, A. Diagnostic and treatment workup for IgG4-related disease. Expert Rev Clin Immunol 2017;13:867–875.</td></tr>
                                <tr><td><strong>103</strong></td><td>Khan S, Del-Duca C, Fenton E, Holding S, Hirst J, Doré PC et al. Limited value of testing for intrinsic factor antibodies with negative gastric parietal cell antibodies in pernicious anaemia. J Clin Path 2009;62:439–441.</td></tr>
                                <tr><td><strong>104</strong></td><td>NICE. Anaphylaxis: Assessment and Referral After Emergency Treatment. London, UK: NICE, 2011. Available at: www.nice.org.uk/guidance/cg134</td></tr>
                                <tr><td><strong>105</strong></td><td>Ntatsaki E, Carruthers D, Chakravarty K, D'Cruz D, Harper L, Jayne D et al. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology 2014;53:2306–2309.</td></tr>
                                <tr><td><strong>106</strong></td><td>Crobach MJT, Planche T, Eckert C, Barbut F, Terveer EM, Dekkers OM et al. European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect 2016;22:S63– S81.</td></tr>
                                <tr><td><strong>107</strong></td><td>Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001;97:1604–1610.</td></tr>
                                <tr><td><strong>108</strong></td><td>Furfaro E, Mikulska M, Miletich F, Viscoli C. Galactomannan: testing the same sample twice? Transpl Infect Dis 2012;14:E38–E39.</td></tr>
                                <tr><td><strong>109</strong></td><td>Leeflang MM, Debets-Ossenkopp YJ, Vissers CE, Scholten RJ, Hooft L, Bijlmer HA et al. Galactomannan detection for invasive aspergillosis in immunocompromized patients (Review). Cochrane Database Syst Rev 2008;4:CD007394.</td></tr>
                                <tr><td><strong>110</strong></td><td>Chai LY, Kullberg BJ, Johnson EM, Teerenstra S, Khin LW, Vonk AG et al. Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis. J Clin Microbiol 2012;50:2330–2336.</td></tr>
                                <tr><td><strong>111</strong></td><td>Nouer SA, Nucci M, Kumar NS, Grazziutti M, Barlogie B, Anaissie E. Earlier response assessment in invasive aspergillosis based on the kinetics of serum aspergillus galactomannan: proposal for a new definition. Clin Infect Dis 2011;53:671–676.</td></tr>
                                <tr><td><strong>112</strong></td><td>Bergeron A, Porcher R, Menotti J, Poirot JL, Chagnon K, Vekhoff A et al. Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients. J Clin Microbiol 2012;50:823–830.</td></tr>
                                <tr><td><strong>113</strong></td><td>Schelenz S, Barnes RA, Barton RC, Cleverley JR, Lucas SB, Kibbler CC et al. British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases. Lancet Infect Dis 2015;15:461–474.</td></tr>
                                <tr><td><strong>114</strong></td><td>Lass-Florl C. How to make a fast diagnosis in invasive aspergillosis. Med Mycol 2019;57:S155–S160.</td></tr>
                                <tr><td><strong>115</strong></td><td>Eggimann P, Marchetti O. Is (1→3)-β-D-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis? Crit Care 2011;15:1017.</td></tr>
                                <tr><td><strong>116</strong></td><td>Cuenca-Estrella M, Verweij PE, Arendrup MC, Arikan-Akdagli S, Bille J, Donnelly JP et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 2012;18:S9–S18.</td></tr>
                                <tr><td><strong>117</strong></td><td>Hammarström H, Kondori N, Friman V, Wennerås C. How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors. Eur J Clin Microbiol Infect Dis 2015;34:917–925.</td></tr>
                                <tr><td><strong>118</strong></td><td>Rautemaa-Richardson R, Rautemaa V, Al-Wathiqi F, Moore CB, Craig L, Felton TW et al. Impact of a diagnostics-driven antifungal stewardship programme in a UK tertiary referral teaching hospital. J Antimicrob Chemother 2018;73:3488–3495.</td></tr>
                                <tr><td><strong>119</strong></td><td>British HIV Association. British HIV Association Guidelines for the Management of HIV in pregnancy and postpartum. London, UK: British HIV Association, 2018.</td></tr>
                                <tr><td><strong>120</strong></td><td>Public Health England. Hepatitis B Guidance on the antenatal screening and selective neonatal immunisation programme.2021.. Available at https://www.gov.uk/government/publications/hepatitis-b-antenatal-screening-and-selective-neonatal-immunisation-pathway</td></tr>
                                <tr><td><strong>121</strong></td><td>Public Health England. UK Standards for Microbiological Investigations V8: Vertical and Perinatal Transmission of Hepatitis C. London, UK: Public Health England, 2018.</td></tr>
                                <tr><td><strong>122</strong></td><td>The Renal Association. Clinical Practice Guideline Management of Blood Borne Viruses within the Haemodialysis Unit. Bristol, UK: The Renal Association, 2019.</td></tr>
                                <tr><td><strong>123</strong></td><td>Department of Health. Good Practice Guidelines for Renal Dialysis/Transplantation Units: Prevention and Control of Blood-borne Virus Infection. London, UK: Department of Health, 2002.</td></tr>
                                <tr><td><strong>124</strong></td><td>Department of Health. HIV Post-Exposure Prophylaxis. In: Guidance from the UK Chief Medical Officers' Expert Advisory Group on AIDS. London, UK: Department of Health, 2008.</td></tr>
                                <tr><td><strong>125</strong></td><td>BASHH Guidelines. BASHH/EAGA Statement on HIV Window Period. Accessed July 2019. Available at: www.bashhguidelines.org/media/1069/bashh-eaga-statement-on-hiv-wp-nov-14.pdf</td></tr>
                                <tr><td><strong>126</strong></td><td>Ramsay ME. Guidance on the investigation and management of occupational exposure to hepatitis C. Commun Dis Public Health 1999;2:258–262</td></tr>
                            </tbody>
                        </table>
                    </div>
                </div>
            </div>
        </div>
    </div>
</div>
<script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.0/dist/js/bootstrap.bundle.min.js"></script>
</body>
</html>
